Related Experiment Video
Updated: Nov 11, 2025

09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.8K
The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders
Iman Imtiyaz Ahmed Juvale1, Ahmad Tarmizi Che Has2
1Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia.
Journal of Molecular Neuroscience : MN
|March 28, 2021
Summary
MicroRNAs show promise as biomarkers for early diagnosis of neurodevelopmental disorders. Understanding their role could improve early detection and patient outcomes for conditions like autism and ADHD.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Neurodevelopmental disorders (NDDs) manifest early in childhood with cognitive, behavioral, and functional deficits.
- Examples include autism spectrum disorder, ADHD, and Down syndrome, affecting millions globally.
- Current understanding of NDD molecular mechanisms is limited, hindering early diagnosis and effective treatment.
Purpose of the Study:
- To review the current understanding of microRNA roles in neurodevelopmental disorders.
- To explore the potential of microRNAs as diagnostic biomarkers for NDDs.
- To highlight the need for improved diagnostic tools for better patient prognosis.
Main Methods:
- Literature review focusing on microRNA regulation in central nervous system development.
- Analysis of studies linking altered microRNA expression to NDDs.
- Synthesis of current knowledge on microRNAs in neurodevelopment.
Main Results:
- MicroRNAs (miRNAs) are small non-coding RNAs involved in gene regulation.
- Altered miRNA expression patterns are observed in various neurodevelopmental disorders.
- miRNAs play a crucial role in neurodevelopmental processes and their dysregulation contributes to NDDs.
Conclusions:
- MicroRNAs represent a promising avenue for developing novel diagnostic biomarkers for NDDs.
- Early detection through miRNA biomarkers could significantly improve patient outcomes and quality of life.
- Further research into miRNA function and regulation is essential for clinical applications in NDDs.
Related Concept Videos
MicroRNAs
3.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs
22.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K

